Ulipristal

Chemical formula: C₃₀H₃₇NO₄  Molecular mass: 433.592 g/mol  PubChem compound: 13559281

Active ingredient description

Ulipristal is an orally-active synthetic selective progesterone receptor modulator which acts via high-affinity binding to the human progesterone receptor. When used for emergency contraception the mechanism of action is inhibition or delay of ovulation via suppression of the luteinising hormone (LH) surge. Pharmacodynamic data show that even when taken immediately before ovulation is scheduled to occur (when LH has already started to rise), ulipristal acetate is able to postpone follicular rupture for at least 5 days.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
G03AD02 Ulipristal G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AD Emergency contraceptives
Discover more medicines within G03AD02
G03XB02 G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03X Other sex hormones and modulators of the genital system → G03XB Antiprogestogens
Discover more medicines within G03XB02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ELLA Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
ELLAONE Tablet European Medicines Agency (EU) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 159811-51-5
DrugBank Drug: DB08867
KEGG Drug: D09567
PubChem Compound: 13559281
RxNorm Ingredient: 1005921
SNOMED-CT Concept: 703249005
Ulipristal (substance)
UNII Identifier: 6J5J15Q2X8
ULIPRISTAL

Medicines

Ulipristal is an active ingredient of these brands:

United States (US)

  • ELLA as ULIPRISTAL ACETATE

Austria (AT)

Canada (CA)

  • ELLA as ULIPRISTAL ACETATE

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

  • ELLAONE as ULIPRISTAL ACETATE
  • ESMYA as ULIPRISTAL ACETATE
  • FEMKE as ULIPRISTAL ACETATE

France (FR)

Hong Kong (HK)

  • ELLA as ULIPRISTAL ACETATE
  • ESMYA as ULIPRISTAL ACETATE

Ireland (IE)

Israel (IL)

  • ELLA as ULIPRISTAL ACETATE
  • ESMYA as ULIPRISTAL ACETATE

Lithuania (LT)

Malta (MT)

  • ECINQ as ULIPRISTAL ACETATE

Netherlands (NL)

Poland (PL)

Romania (RO)

  • ELLAONE as ULIPRISTAL ACETATE
  • ESMYA as ULIPRISTAL ACETATE
  • FEMKE as ULIPRISTAL ACETATE

Singapore (SG)

  • ELLA as ULIPRISTAL ACETATE
  • ESMYA as ULIPRISTAL ACETATE

Spain (ES)

Tunisia (TN)

Turkey (TR)

  • ELLA as ULIPRISTAL ACETATE
  • JOSEI as ULIPRISTAL ACETATE
  • ULPISAD as ULIPRISTAL ACETATE

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.